Hospitals have made significant efforts to comply with price transparency regulations due to increased civil monetary penalties from CMS, according to a recent JAMA Network Open study.Read More »
CMS could pay certain eligible hospitals approximately $9 billion in total as part of its plan to remedy unlawful cuts to the 340B drug discount program between 2018 and 2022, according to a proposed rule. However, the remedy would come at the cost of cuts to non-drug items and services...Read More »
CMS is proposing a coverage pathway to achieve expedited and more predictable access to new medical technologies for Medicare beneficiaries.Read More »
CMS recently released a list of the 43 Part B drugs and biologicals that will be included in the Medicare Prescription Drug Inflation Rebate Program for July 1–September 30.Read More »
A bipartisan group of over 30 senators recently wrote a letter to CMS to ask the agency to reevaluate the fiscal year (FY) 2024 Inpatient Prospective Payment System (IPPS) proposed rule.Read More »
Although commercial payers typically pay more per claim, it is significantly easier for providers to get reimbursed by Medicare, according to a May 2023 Crowe Revenue Cycle Analytics report.Read More »